MDL | MFCD00813905 |
---|---|
Molecular Weight | 266.09 |
Molecular Formula | C10H8BrN3O |
SMILES | O=C1NC(N)=NC(C2=CC=CC=C2)=C1Br |
Bropirimine is a synthetic agonist for toll-like receptor 7 (TLR7) . Bropirimine inhibits differentiation of osteoclast precursor cells into osteoclasts via TLR7-mediated production of IFN-β. Bropirimine is an orally active immunomodulator that has demonstrated anticancer activity in transitional cell carcinoma in situ (CIS) in both the bladder and upper urinary tract [1] [2] .
Solid
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : 50 mg/mL ( 187.91 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.7581 mL | 18.7906 mL | 37.5813 mL |
5 mM | 0.7516 mL | 3.7581 mL | 7.5163 mL |
10 mM | 0.3758 mL | 1.8791 mL | 3.7581 mL |